Heparin prophylaxis for intraocular fibrin
- PMID: 3627708
- DOI: 10.1016/s0161-6420(87)33403-7
Heparin prophylaxis for intraocular fibrin
Abstract
The authors have evaluated the use of heparin as a method to prevent postoperative intraocular fibrin clot formation in the rabbit after vitrectomy and cyclocryotherapy. In addition, they have studied the effect of a heparin infusion on intraocular bleeding after sectioning of retinal vessels. Heparin was administered by several different routes. The extent of the postoperative fibrin clot, as well as the number of days until its clearing, were recorded. A single anterior chamber injection, heparin supplementation of the infusion solution, or a single intravenous (IV) injection, all resulted in a statistically significant reduction of postoperative intraocular fibrin. Once daily subcutaneous injections alone did not produce a reduction in postoperative fibrin. No ocular bleeding complications developed postoperatively. A constant heparin intraocular infusion of 10 IU/cc did not change the bleeding time after sectioning of a retinal vessel.
Similar articles
-
A prospective, randomized, clinical trial of heparin therapy for postoperative intraocular fibrin.Ophthalmology. 1988 Mar;95(3):312-7. doi: 10.1016/s0161-6420(88)33181-7. Ophthalmology. 1988. PMID: 3173998 Clinical Trial.
-
Tissue plasminogen activator treatment of postoperative intraocular fibrin.Ophthalmology. 1988 May;95(5):592-6. doi: 10.1016/s0161-6420(88)33140-4. Ophthalmology. 1988. PMID: 3140157
-
Inhibition of intraocular fibrin formation following infusion of low-molecular-weight heparin during vitrectomy.Arch Ophthalmol. 1991 Mar;109(3):405-9. doi: 10.1001/archopht.1991.01080030107048. Arch Ophthalmol. 1991. PMID: 2003803
-
Intraocular injection of recombinant hirudin to prevent experimental postoperative fibrin.Retina. 1997;17(4):315-20. doi: 10.1097/00006982-199707000-00007. Retina. 1997. PMID: 9279948
-
Thromboelastographic modifications induced by intravenous and subcutaneous heparin administration.Semin Thromb Hemost. 1995;21 Suppl 4:53-8. doi: 10.1055/s-0032-1313622. Semin Thromb Hemost. 1995. PMID: 8747689 Review. No abstract available.
Cited by
-
A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy.Graefes Arch Clin Exp Ophthalmol. 2005 Jul;243(7):701-5. doi: 10.1007/s00417-004-0912-0. Epub 2005 Mar 3. Graefes Arch Clin Exp Ophthalmol. 2005. PMID: 15744529
-
Intravitreal recombinant tissue plasminogen activator in the treatment of experimentally induced bacterial endophthalmitis.Int Ophthalmol. 1991 Mar;15(2):79-86. doi: 10.1007/BF01046426. Int Ophthalmol. 1991. PMID: 1902438
-
Heparinised intraocular infusion and bacterial contamination in cataract surgery.Br J Ophthalmol. 1997 Nov;81(11):949-52. doi: 10.1136/bjo.81.11.949. Br J Ophthalmol. 1997. PMID: 9505816 Free PMC article. Clinical Trial.
-
Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy?Graefes Arch Clin Exp Ophthalmol. 1996 Aug;234(8):496-503. doi: 10.1007/BF00184858. Graefes Arch Clin Exp Ophthalmol. 1996. PMID: 8858355 Clinical Trial.
-
Effect of low molecular weight heparin (enoxaparin) on congenital cataract surgery.Int J Ophthalmol. 2012;5(5):596-9. doi: 10.3980/j.issn.2222-3959.2012.05.10. Epub 2012 Oct 18. Int J Ophthalmol. 2012. PMID: 23166871 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical